Archive: 11/09/2011

Results of the BRIDGE trial reported at TCT 2011

Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was effective at maintaining platelet inhibition in patients on thienopyridines who required bypass surgery. Trial ...

Nov 09, 2011
popularity 3 / 5 (1) | comments 0

Results of the TRIGGER-PCI trial reported at TCT 2011

A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet reactivity (HCPR) following percutaneous coronary intervention (PCI) was ended early due to relatively few occurrences of ...

Nov 09, 2011
popularity 5 / 5 (2) | comments 0

Results of the PARIS registry Reported at TCT 2011

Non-adherence to antiplatelet therapy – which prevents blood clots following percutaneous coronary intervention (PCI) – was associated with higher rates of both ischemic and bleeding events at 30 days. Results of ...

Nov 09, 2011
popularity not rated yet | comments 0

Results of the DESERT registry reported at TCT 2011

The risk of late stent thrombosis (ST) in the first generation of drug-eluting stents continues for up to seven years after implantation, and certain types of patients, including smokers and those who are younger, are at ...

Nov 09, 2011
popularity not rated yet | comments 0

World's first bedside genetic test proves effective

Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) ...

Nov 09, 2011
popularity not rated yet | comments 0 | with audio podcast